DHGWA
BIIB icon

Dixon Hughes Goodman Wealth Advisors’s Biogen BIIB Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$5K Buy
24
+21
+700% +$4.57K ﹤0.01% 589
2021
Q4 		$1K Buy
+3
New +$771 ﹤0.01% 717

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's BIIB Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors increased its Biogen (BIIB) stake by 700% in Q1 2022, buying an estimated $4.57K and bringing the position to 24 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #589.

Dixon Hughes Goodman Wealth Advisors first reported a position in BIIB in Q4 2021 and has held it in 2 quarters since. 952 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • Dixon Hughes Goodman Wealth Advisors held 24 shares of Biogen worth $5K as of Q1 2022.
  • Dixon Hughes Goodman Wealth Advisors bought 21 Biogen shares in Q1 2022, an estimated $4.57K.
  • Biogen made up ﹤0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #589 holding.
  • Dixon Hughes Goodman Wealth Advisors first reported a position in Biogen in Q4 2021 and has held it in 2 quarters since.
  • 952 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.